CA2078327A1 - Plant promoter - Google Patents
Plant promoterInfo
- Publication number
- CA2078327A1 CA2078327A1 CA002078327A CA2078327A CA2078327A1 CA 2078327 A1 CA2078327 A1 CA 2078327A1 CA 002078327 A CA002078327 A CA 002078327A CA 2078327 A CA2078327 A CA 2078327A CA 2078327 A1 CA2078327 A1 CA 2078327A1
- Authority
- CA
- Canada
- Prior art keywords
- gene
- promoter
- sequence
- plant
- vector
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 114
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 31
- 239000002773 nucleotide Substances 0.000 claims abstract description 19
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 19
- 230000014509 gene expression Effects 0.000 claims abstract description 18
- 238000003780 insertion Methods 0.000 claims abstract description 5
- 230000037431 insertion Effects 0.000 claims abstract description 5
- 238000012217 deletion Methods 0.000 claims abstract description 4
- 230000037430 deletion Effects 0.000 claims abstract description 4
- 238000006467 substitution reaction Methods 0.000 claims abstract description 4
- 239000012634 fragment Substances 0.000 claims description 46
- 239000013598 vector Substances 0.000 claims description 38
- 230000009261 transgenic effect Effects 0.000 claims description 19
- 239000013612 plasmid Substances 0.000 claims description 14
- 238000000034 method Methods 0.000 claims description 7
- 230000001172 regenerating effect Effects 0.000 claims description 3
- 230000001131 transforming effect Effects 0.000 claims description 3
- 241000196324 Embryophyta Species 0.000 description 72
- 210000004027 cell Anatomy 0.000 description 35
- 239000000523 sample Substances 0.000 description 34
- 101710129170 Extensin Proteins 0.000 description 30
- 108020004414 DNA Proteins 0.000 description 27
- 235000018102 proteins Nutrition 0.000 description 19
- 238000009396 hybridization Methods 0.000 description 18
- 244000061176 Nicotiana tabacum Species 0.000 description 17
- 229930027917 kanamycin Natural products 0.000 description 17
- 229960000318 kanamycin Drugs 0.000 description 17
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 17
- 229930182823 kanamycin A Natural products 0.000 description 17
- 239000002299 complementary DNA Substances 0.000 description 16
- 108091026890 Coding region Proteins 0.000 description 15
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 13
- 239000002609 medium Substances 0.000 description 13
- 241000894007 species Species 0.000 description 13
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 12
- 240000002791 Brassica napus Species 0.000 description 12
- 108010060309 Glucuronidase Proteins 0.000 description 11
- 229920001817 Agar Polymers 0.000 description 10
- 235000006008 Brassica napus var napus Nutrition 0.000 description 10
- 102000053187 Glucuronidase Human genes 0.000 description 10
- 239000008272 agar Substances 0.000 description 10
- 108020004999 messenger RNA Proteins 0.000 description 9
- 150000003839 salts Chemical class 0.000 description 9
- 108010058731 nopaline synthase Proteins 0.000 description 8
- 238000002105 Southern blotting Methods 0.000 description 7
- 229930006000 Sucrose Natural products 0.000 description 7
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 7
- 238000004458 analytical method Methods 0.000 description 7
- 239000005720 sucrose Substances 0.000 description 7
- 238000013518 transcription Methods 0.000 description 7
- 230000035897 transcription Effects 0.000 description 7
- 241000588724 Escherichia coli Species 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- 108090000765 processed proteins & peptides Proteins 0.000 description 6
- 230000001105 regulatory effect Effects 0.000 description 6
- 108020005065 3' Flanking Region Proteins 0.000 description 5
- 208000034454 F12-related hereditary angioedema with normal C1Inh Diseases 0.000 description 5
- 108091028043 Nucleic acid sequence Proteins 0.000 description 5
- FPPNZSSZRUTDAP-UWFZAAFLSA-N carbenicillin Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)C(C(O)=O)C1=CC=CC=C1 FPPNZSSZRUTDAP-UWFZAAFLSA-N 0.000 description 5
- 229960003669 carbenicillin Drugs 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 230000004927 fusion Effects 0.000 description 5
- 208000016861 hereditary angioedema type 3 Diseases 0.000 description 5
- 210000000056 organ Anatomy 0.000 description 5
- 229920001184 polypeptide Polymers 0.000 description 5
- 102000004196 processed proteins & peptides Human genes 0.000 description 5
- 230000002103 transcriptional effect Effects 0.000 description 5
- 241000589155 Agrobacterium tumefaciens Species 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 4
- 238000000636 Northern blotting Methods 0.000 description 4
- 150000001413 amino acids Chemical group 0.000 description 4
- 230000009466 transformation Effects 0.000 description 4
- 235000011293 Brassica napus Nutrition 0.000 description 3
- 240000000385 Brassica napus var. napus Species 0.000 description 3
- 108700007698 Genetic Terminator Regions Proteins 0.000 description 3
- 108010025815 Kanamycin Kinase Proteins 0.000 description 3
- 108091081024 Start codon Proteins 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 239000003242 anti bacterial agent Substances 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 230000003115 biocidal effect Effects 0.000 description 3
- 229960004261 cefotaxime Drugs 0.000 description 3
- GPRBEKHLDVQUJE-VINNURBNSA-N cefotaxime Chemical compound N([C@@H]1C(N2C(=C(COC(C)=O)CS[C@@H]21)C(O)=O)=O)C(=O)/C(=N/OC)C1=CSC(N)=N1 GPRBEKHLDVQUJE-VINNURBNSA-N 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 238000011081 inoculation Methods 0.000 description 3
- 238000012163 sequencing technique Methods 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- -1 vitamins) Chemical class 0.000 description 3
- 102000040650 (ribonucleotides)n+m Human genes 0.000 description 2
- 108020005029 5' Flanking Region Proteins 0.000 description 2
- 235000004977 Brassica sinapistrum Nutrition 0.000 description 2
- 241001137903 Centropomus pectinatus Species 0.000 description 2
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 2
- 244000000626 Daucus carota Species 0.000 description 2
- 235000002767 Daucus carota Nutrition 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 241001131785 Escherichia coli HB101 Species 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 108060002716 Exonuclease Proteins 0.000 description 2
- 206010020649 Hyperkeratosis Diseases 0.000 description 2
- FAIXYKHYOGVFKA-UHFFFAOYSA-N Kinetin Natural products N=1C=NC=2N=CNC=2C=1N(C)C1=CC=CO1 FAIXYKHYOGVFKA-UHFFFAOYSA-N 0.000 description 2
- 108700005084 Multigene Family Proteins 0.000 description 2
- 108091034057 RNA (poly(A)) Proteins 0.000 description 2
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
- 241000607479 Yersinia pestis Species 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 239000002361 compost Substances 0.000 description 2
- 102000013165 exonuclease Human genes 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- QANMHLXAZMSUEX-UHFFFAOYSA-N kinetin Chemical compound N=1C=NC=2N=CNC=2C=1NCC1=CC=CO1 QANMHLXAZMSUEX-UHFFFAOYSA-N 0.000 description 2
- 229960001669 kinetin Drugs 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 2
- 238000013507 mapping Methods 0.000 description 2
- 230000013011 mating Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 239000013600 plasmid vector Substances 0.000 description 2
- 210000001938 protoplast Anatomy 0.000 description 2
- 239000002689 soil Substances 0.000 description 2
- 229910021653 sulphate ion Inorganic materials 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 229960003495 thiamine Drugs 0.000 description 2
- 230000014621 translational initiation Effects 0.000 description 2
- 108700026220 vif Genes Proteins 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- PRPINYUDVPFIRX-UHFFFAOYSA-N 1-naphthaleneacetic acid Chemical compound C1=CC=C2C(CC(=O)O)=CC=CC2=C1 PRPINYUDVPFIRX-UHFFFAOYSA-N 0.000 description 1
- 239000005971 1-naphthylacetic acid Substances 0.000 description 1
- JXCKZXHCJOVIAV-UHFFFAOYSA-N 6-[(5-bromo-4-chloro-1h-indol-3-yl)oxy]-3,4,5-trihydroxyoxane-2-carboxylic acid;cyclohexanamine Chemical compound [NH3+]C1CCCCC1.O1C(C([O-])=O)C(O)C(O)C(O)C1OC1=CNC2=CC=C(Br)C(Cl)=C12 JXCKZXHCJOVIAV-UHFFFAOYSA-N 0.000 description 1
- 229930024421 Adenine Natural products 0.000 description 1
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
- 241000589158 Agrobacterium Species 0.000 description 1
- 241000219310 Beta vulgaris subsp. vulgaris Species 0.000 description 1
- 235000011331 Brassica Nutrition 0.000 description 1
- 241000219198 Brassica Species 0.000 description 1
- 235000014698 Brassica juncea var multisecta Nutrition 0.000 description 1
- 235000006618 Brassica rapa subsp oleifera Nutrition 0.000 description 1
- 108020004705 Codon Proteins 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 244000241257 Cucumis melo Species 0.000 description 1
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 239000003298 DNA probe Substances 0.000 description 1
- 241001303048 Ditta Species 0.000 description 1
- 108010042407 Endonucleases Proteins 0.000 description 1
- 102000004533 Endonucleases Human genes 0.000 description 1
- 241000588722 Escherichia Species 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 241000219146 Gossypium Species 0.000 description 1
- 235000003222 Helianthus annuus Nutrition 0.000 description 1
- 244000020551 Helianthus annuus Species 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- 240000008415 Lactuca sativa Species 0.000 description 1
- 235000003228 Lactuca sativa Nutrition 0.000 description 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 108091092724 Noncoding DNA Proteins 0.000 description 1
- 101710163270 Nuclease Proteins 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 108700026244 Open Reading Frames Proteins 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 240000007377 Petunia x hybrida Species 0.000 description 1
- 108700001094 Plant Genes Proteins 0.000 description 1
- 108010064851 Plant Proteins Proteins 0.000 description 1
- 108091036407 Polyadenylation Proteins 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 241000219000 Populus Species 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 108091081062 Repeated sequence (DNA) Proteins 0.000 description 1
- 102000006382 Ribonucleases Human genes 0.000 description 1
- 108010083644 Ribonucleases Proteins 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 101710172711 Structural protein Proteins 0.000 description 1
- 235000021536 Sugar beet Nutrition 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- FJJCIZWZNKZHII-UHFFFAOYSA-N [4,6-bis(cyanoamino)-1,3,5-triazin-2-yl]cyanamide Chemical compound N#CNC1=NC(NC#N)=NC(NC#N)=N1 FJJCIZWZNKZHII-UHFFFAOYSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 229960000643 adenine Drugs 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 230000021615 conjugation Effects 0.000 description 1
- 108091036078 conserved sequence Proteins 0.000 description 1
- 230000001351 cycling effect Effects 0.000 description 1
- 230000023753 dehiscence Effects 0.000 description 1
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 1
- 238000004520 electroporation Methods 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 238000011331 genomic analysis Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 230000001744 histochemical effect Effects 0.000 description 1
- 229960002591 hydroxyproline Drugs 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 235000009973 maize Nutrition 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000000520 microinjection Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000001483 mobilizing effect Effects 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- VVQQKXATELLTFX-UHFFFAOYSA-N n-(furan-2-ylmethyl)-7h-purin-2-amine Chemical compound N=1C=C2NC=NC2=NC=1NCC1=CC=CO1 VVQQKXATELLTFX-UHFFFAOYSA-N 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 231100000590 oncogenic Toxicity 0.000 description 1
- 230000002246 oncogenic effect Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 235000019362 perlite Nutrition 0.000 description 1
- 239000010451 perlite Substances 0.000 description 1
- 235000021118 plant-derived protein Nutrition 0.000 description 1
- 238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 230000037452 priming Effects 0.000 description 1
- 230000000644 propagated effect Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- JQXXHWHPUNPDRT-WLSIYKJHSA-N rifampicin Chemical compound O([C@](C1=O)(C)O/C=C/[C@@H]([C@H]([C@@H](OC(C)=O)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)\C=C\C=C(C)/C(=O)NC=2C(O)=C3C([O-])=C4C)C)OC)C4=C1C3=C(O)C=2\C=N\N1CC[NH+](C)CC1 JQXXHWHPUNPDRT-WLSIYKJHSA-N 0.000 description 1
- 229960001225 rifampicin Drugs 0.000 description 1
- 239000012882 rooting medium Substances 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000010153 self-pollination Effects 0.000 description 1
- 238000002741 site-directed mutagenesis Methods 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- QTENRWWVYAAPBI-YCRXJPFRSA-N streptomycin sulfate Chemical compound OS(O)(=O)=O.OS(O)(=O)=O.OS(O)(=O)=O.CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](N=C(N)N)[C@H](O)[C@@H](N=C(N)N)[C@H](O)[C@H]1O.CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](N=C(N)N)[C@H](O)[C@@H](N=C(N)N)[C@H](O)[C@H]1O QTENRWWVYAAPBI-YCRXJPFRSA-N 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 230000017260 vegetative to reproductive phase transition of meristem Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 230000001018 virulence Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8216—Methods for controlling, regulating or enhancing expression of transgenes in plant cells
- C12N15/8222—Developmentally regulated expression systems, tissue, organ specific, temporal or spatial regulation
- C12N15/8223—Vegetative tissue-specific promoters
- C12N15/8227—Root-specific
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Botany (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
A promoter which is capable of directing protein expression in roots in plants and which has: (a) the sequence from nucleotide -1616 to nucleotide -1 shown in Figure 1 or a part of the said sequence or (b) a said sequence (a) modified by one or more nucleotide substitutions, insertions and/or deletions and/or by an extension at either or each end.
Description
2 PCTtGB9~/00416 ! `~, 2 9 7 ~ 3 2 7 !- '' PLANT PROMOTER
The present invention relates to a plant promoter.
Extensin is the best characterised structural protein in the walls of plant cells (Cassab and Varner, Ann.
Rev. Plant Physiol. 39, 321-353, 1988). It is a member of a class of highly basic, hydroxyproline-rich glycoproteins present in a wide variety of plants. Extensin has been reported to be present at greatest abundance in sclerenchyma tissues and a variety of functional roles have been ascribed to the protein, including mechanical strengthening and organisation of the cell wall. Extensins vary in their ~ -primary structure in different plants, organs and tissues.
In some cases, there are two different extensins within the same tissue or cell type, which may be function-related.
As part of a programme to isolate plant genes expressed in an organ-specific manner, mRNA species present in the roots of oilseed rape (Brassica napus L.) were investigated, with the aim of isolating se~uences abundant in root but not in other tissues. A family of cross-hybridising sequences present at highly enhanced levels in root has been isolated, characterised, and shown to encode proteins homologous to extensin. This has enabled us to identify a promoter capable of directing the expression of proteins in roots.
Accordingly, the present invention provides a promoter which is capable of directing protein expression in roots of plants and which has:
(a) the seguence from nucleotide -1616 to nucleotide -1 shown in ~igure 1 or a part of the said sequence or ; (b) a said sequence (a) modified by one or more nucleotide substitutions, insertions and/or deletions and/or by an extension at either or each end.
The invention also provides a DNA fragment comprisin~ such a promoter operably linked to a gene, i : - , :: . : . . . .
: . .- . -. .. . :
. . -,: . . : ~ , . :...... ~ . :
- , "
. , . : . , . .: :
2~78327 ~
typically a heterologous gene encoding a protein.
Additionally provided is a vector which comprises a gene encoding a protein under the control of a promoter as above such that the gene is capable of being expressed in a plant cell transformed with the vector. A suitable vector is one in which the promoter is fused directly to the 5'-end of the gene. The vector may further contain a region which enables the gene and the promoter to be transferred to and stably integrated in a plant cell genome. The vector is generally a plasmid.
Plant cells can be transformed with such a vector.
The invention therefore further provides plant cells which harbour a promoter as above operably linked to a gene encoding a protein. Transgenic plants may be regenerated from such plant cells. A transgenic plant can be obtained which harbours in its cells a promoter as above operably linked to a gene encoding a protein. Seed may be obtained from the transgenic plants. Plants may in turn be grown from this seed.
The invention additionally provides a method of producing a transgenic plant capable of producing a desired protein in the roots of the plant, which method comprises:
(i) transforming a plant cell with a vector according to the invention, the protein encoded by the gene under the control of the said promoter being the desired protein; and (ii) regenerating plants from the transformed cells.
In the accompanying drawings:
Figure l shows the nucleotide sequence of gene extA, with the predicted amino acid sequence of the rape extensin polypeptide, and the sequence of the promoter of the invention from nucleotide -1616 to nucleotide -l. The complete sequence is the sequence of the 2.7kb HincII-HincII
fragment shown in Figure 2. The predicted site of cleavage of the leader sequence is indicated by a colon (:). The ~: , , .: , . . , - :
: - . . - . . : . ~ -: . .
. . , . . .. ~ : :
,. . . . ..
. ~ .: .
.. . . . .
. . . : : . .. . : ... . ~ . ~
WO91/t3992 PCT/GB91/00416 ~ 2978327 transcription start point is indicated by a circumflex (T^S), and a sequence similar to the consensus "TATA"
control box is also indicated. Other sequence features are as indicated on the Figure.
Figure 2 is a restriction map of the oilseed rape genomic clone lambdaB31 (12.7 kb) encoding gene extA, a restriction map of pRlambdaS4, a HindIII-AvaI fragment from lambdaB31 in pUC18, and a sequencing map of the 2.7kb HincII-HincII fragment containing extA. ra and la, indicate right arm and left arm of the EMBL 3 lambda vector, respectively; ~ \ \\\~ indicates coding sequence.
Sa/H2-Al/Sm/Xl fragment is a part of EMBL 3. Key to restriction site symbols on sequencing map: Sa, Sal I; H3, Hind III; Sm, SmaI; H2, Hinc II; Pl, Pst I; AI, AvaI; XI, Xma I; Ns, Nsi I; RI, Rsa I; Ha, Hae III; Ss, Ssp I; Nd, Nde I; Pv, Pvu II.
Figure 3 shows a detailed restriction map of pRlambdaS4, a sub-clone from ~B31 comprising a HindIII-AvaI
fragm~nt of lambdaB31 in pUC18.~ shows the location and direction of transcription of the extensin coding sequence.
There are no sites in the insert for PvuI, XhoI, BscI, BamHI, BglII and EcoRV.
Figure 4 shows a simplified restriction map of the sub-clone pRlambdaS4;~ indicates the position of the extensin coding sequence andl lindicates the region containing the promoter conferring root expression.
Figure 5 is a map of the hybrid gene employed in Example 2; ~ indicates the nopaline synthase (NOS) terminator.
Figure 6 is a map of the hybrid gene from Figure 5 in the vector BIN 19.
Figure 7 shows the rape extensin promoter on a HaeIII fragment excised from lambdaB3I, as described in Exampl~ 3.
Figure 8 shows the fusion construct comprising the rape extensin promoter and the glucuronidase gene coding ..
'; , ' ', '' ' 2~783`%~
sequence, prepared in Example 3.
The full length promoter of the invention is composed of the sequence upstream of the oilseed rape extA
gene, from nucleotide -1616 to nucleotide -1 in Figure 1, base 1 being the adenine (~) base of the CAT transcriptional start codon for the extA gene. The promoter may be obtained from a clone, lambdaB31 by excision on a 4.5kb HindIII-AvaI
fragment (Figure 3). Clone lambdaB31 was obtained from a genomic library prepared from oilseed rape (Brassica naPus L). The HindIII-AvaI fragment was subcloned in pUC18 as pRlambdaS4 from which the promoter can be excised as a 0.96kb HaeIII fragment. E. coli D~5~ harbouring pRlambdaS4 and bacteriophase lambdaB31 have been deposited at the National Collection of Industrial and Marine Bacteria, Aberdeen, GB on 8 March 1990 under accession numbers NCIMB
40265 and NCIMB 40266.
A part of the full length sequence from nucleotide -1616 to nucleotide -1 and modified forms of the full length or part sequence are alternative promoters according to the invention. The full length or part promoter sequence may be modified by one or more nucleotide-substitutions, insertions -and/or deletions and/or by an extension at either or both ends. Any part or modified promoter sequence must however still be capable of acting as a promoter in the roots of plants. When the full length sequence or a part of the full length sequence, i.e. an unmodified sequence, is modified typically there is a degree of homology of at least 60 between a modified sequence and the unmodified natural sequence. The degree of homology may be at least 75~, at least 85~ or at least 95%.
A part of the full length promoter sequence may be obtained by use of restriction endonucleases and/or exonucleases. The promoter may be obtained as a 0.96 kb fragment by treating the sequence shown in Figure 1 with HaeIII. A modified sequence may be obtained by introducing changes into an unmodified promoter sequence. This may be .~
.,, - :
. : . . . . .. :
: . . . . . .
. .. . . : . . : .. . . , ~ : ... :
: .. . .. .
WO9l/13992 PCT/GB91/OW16 ~ 2~783~7 achieved by any appropriate technique, including restriction of the natural sequence with an endonuclease, insertion of oligonucleotide linker adapters, use of an exonuclease and/or a polymerase and site-directed mutagenesis.
Whether a part of the full length promoter sequence or a modified sequence is capable of acting as a promoter may be readily ascertained by experiment. The putative promoter sequence is fused to the glucuronidase coding sequence in the plomoter-less binary vector pBI101 at the SmaI site as described in Example 3. Following the procedure of Example 3, expression of glucuronidase is investigated in the transgenic hairy roots produced.
The promoter may be operably linked to a gene, typically a heterologous gene, encoding a protein. The heterologous gene may encode any protein it is desired to express. "Heterologous" means that the gene is not naturally operably linked to the promoter, i.e. a heterologous gene is not the oilseed rape extA gene. The protein may additionally comprise a transit peptide sequence at its N-terminus, encoded within the "heterologous" gene sequence.
The prom~ter is typically used to express proteins in the roots of plants. The protein whose expression is controlled by the promoter may be for example a protein conferring biological control of pests or pathogens, in particular pests or pathogens to which the roots of plants are susceptible.
The promoter sequence may be fused directly to a gene or via a linker. The linker sequence may comprise an intron. Excluding the length of any intron sequence, the linker may be composed of up to 4S bases, for example up to 30 or up to 15 bases.
DNA fragments and vectors can be prepared in which the promoter is operably linked to a gene, typically a heterologous gene. The fragments and vectors may be single or double stranded. Plant cells can be transformed by such . ,: . . :
.
:
~ , . , ' ... . ~ .
WO91~1~992 PCT/GB91/00416 2~32~ - 6 -fragment by direct DNA uptake, or by way of such a vector.
The vector incorporates the gene under the control of the promoter. The vector contains regulatory elements capable of enabling the gene to be expressed in a plant cell transformed with the vector. Such regulatory elements include, besides the promoter, translational initiation and/or termination sequences. The vector typically also contains a region which enables the gene and associated regulatory control elements to be transferred to and be stably integrated in the plant cell genome.
The vector is therefore typically provided with transcriptional regulatory sequences and/or, if not present at the 3'-end of the coding sequence of the gene, a stop codon. A DNA fragment may therefore also incorporate a terminator sequence and other sequences which are capable of enabling the gene to be expressed in plant cells. An enhancer or other element able to increase or decrease levels of expression obtained in particular parts of a plant or under certain conditions may be provided in the DNA
fragment and/or vector. The vector is also typically provided with an antibiotic resistance gene which confers resistance on transformed plant cells, allowing transformed cells, tissues and plants to be selected by growth on appropriate media containing the antibiotic.
Transformed cells are selected by growth in an appropriate medium. Plant tissue can therefore be obtained comprising a plant cell which harbours the gene under the control of the promoter , for example in the plant cell genome. The gene is therefore expressible in the plant cell. Plants can then be regenerated which include the gene and the promoter in their cells, for example integrated in the plant cell genome, such that the gene can be expressed.
The regenerated plants can be reproduced and, for example, seed obtained. Root-specific expression of proteins can therefore be directed by the present promoter in plants.
Alternatively, transformed roots may be grown in culture for ' ,~
. .
-. , . ;, , ~; ~ ,. . .
: , . .. . , . , : -: .
WO 91/13992 PCI/GP~9~ 416 ~ 2~7~327 the purposes of production of proteins, especially plant proteins.
A preferred way of transforming a plant cell is to use Aqrobacterium tumefaciens containing a vector comprising the promoter operably linked to the gene encoding a protein it is wished to express. A hybrid plasmid vector may therefore be employed which comprises:
(a) the gene under the control of the promoter and other regulatory elements capable of enabling the gene to be expressed when integrated in the genome of a plant cell;
(b) at least one DNA sequence which delineates the DNA to be integrated into the plant genome; and (c) a DNA sequence which enables this DNA to be transferred to the plant genome.
Typically the DNA to be integrated into the plant cell genome is delineated by the T-DNA border sequences of a Ti-plasmid. If only one border sequence is present, it is preferably the right border sequence. The DNA sequence which enables the DNA to be transferrec to the plant cell genome is generally the virulence (vir) region of a Ti-plasmid.
The gene and its transcriptional and translational control elements, including the promoter, can therefore be provided between the T-DNA borders of a Ti-plasmid. The plasmid may be a disarmed Ti-plasmid from which the genes for tumorigenicity have been deleted. The gene and its transcriptional and control elements, including the promoter, can, however, be provided between T-DNA borders in a binary vector ln trans with a Ti-plasmid with a vir region. Such a binary vector therefore comprises:
(a) the gene under the control o~ the promoter and other regulatory elements capable of enabling the gene to be expressed when integrated in the genome of a plant cell; and (b) at least one DNA sequence which delineates the DNA to be integrated into the plant genome.
Aarobacterium tumefaciens, therefore, containing a ,. . . . .
, , .
, :, -,:, ' ' ' . , , .. . ~ , . . .
WO91/13g92 PCT/GB91/00416 2~7~27 ~, hybrid plasmid vector or a binary vector ln trans wlth a Ti-plasmid possessing a vir region can be used to transform plant cells. Tissue explants such as stems or leaf discs may be inoculated with the bacterium. Alternatively, the bacterium may be co-cultured with regenerating plant protoplasts. Plant protoplasts may also be transformed by direct introduction of DNA fragments which encode the gene of interest and in which the promoter and appropriate other transcriptional and translational control elements are present or of a vector incorporating such a fragment.
Direct introduction may be achieved using electroporation, polyethylene glycol, microinjection or particle bombardment.
Plant cells from monocotyledonous or dicotyledonous plants can be transformed according to the present invention. Monocotyledonous species include barley, wheat, maize and rice. Dicotyledonous species include tobacco, tomato, sunflower, petunia, cotton, sugarbeet, potato, lettuce, melon, soybean, canola (rapeseed) and poplars.
Tissue cultures of transformed plant cells are propagated to regenerate differentiated transformed whole plants. The transformed plant cells may be cultured on a suitable medium, preferably a selectable growth medium. Plants may be regenerated from the resulting callus. Transgenic plants are thereby obtained whose cells harbour the promoter operably linked to the gene encoding the protein it is wished to express, for example integrated in their genome.
The gene is consequently expressible in the cells. Seed from the regenerated plants can be collected for future use, and plants grown from this seed.
The following Examples illustrate the invention.
1. A family of cross-hybridising cDNA clones was isolated from a cDNA library produced with poly (A) +RNA from the roots of oilseed rape (Brassica naDus L.). The clones were selected as abundantly expressed in root by differential screening of the root CDNA library with cDNA
- ., :, , , . .' :: ;,: ~......... , :' : :
. . ; .
~ ~ ! 2 ~ 7 8 ~ 2 7 g probes prepared from root, green leaf, etiolated leaf and developing seed. mRNA species corresponding to the selected abundant clones were expressed in roots at levels of at least 400 x those in other organs, as shown by Northern blot analysis and RNase protection assays. One of the cDNA
clones was designated pRRt566.
2. An extensin gene designated extA, was obtained from an oilseed rape (Brassica naPus L.) genomic library screened with pRRt566 at high stringency. The gene is a mem~er of a multigene family, consisting of about three members per haploid genome with strong homology to the probe, and a further twenty or so members of weaker homology. The isolated gene, although not identical to the cDNA probe, was also found to be specifically expressed in roots, and was transcribed into a mRNA species of approximately 1300 nucleotides in size. A single transcription start was identified by Sl mapping. A complete nucleotide sequence of the extA gene and its flanking regions was determined. This enabled the gene promoter to be identified. In more de:ail:
Identification of extensln qenes in qenomic DNA
The cDNA species from rape root, pRRt566, previously identified as encoding a protein homologous to extensin, was used as a probe on Southern blots of restrictions of rape genomic DNA. The insert of pRRt566 hybridised to a large number of genomic fragments in all restriction digests, but the strength of hybridisation to all fragments was not equal; 1-2 fragments in all di~ests hybridised at an intensity at least five times that of the other bands. Copy number reconstructions indicated that the strong bands corresponded to approx. 2-3 gene copies per haploid genome: the patterns can be consistently interpreted to give a total of 3 genes per genome highly homologous to this probe. The weakly hybridising fragments were present at less than one estimated copy per haploid genome, and must therefore represent genes that are only partly homologous to the extensin probe. The total sequences detected by this : :
~'091/13992 PCT/GB91/00416 2~7~327 - 10 - ~
probe make up a large multigene family, of which three genes, determined to be closely homologous to pRRt566, form a sub-family. In confirmation of these conclusions, when a 3' flanking sequence probe (240 bp) was prepared from pRRt566, and hybridised to genomic blots as above, hybridisation of this probe to the strongly hybridising bands was identical to that using the whole cDNA insert as a probe, except hybridisation to the pRRt566 weakly hybridising bands was largely eliminated.
Isolation and characterisation of a genomic clone containinq an extensin aene An oilseed rape genomic library, constructed by inserting random Sau 3A fragments of genomic DNA, into lambda EMBL3, was screened at low stringency with a probe prepared from the insert of pRRt566. This cDNA clone was isolated from a library prepared from rape root mRNA, and encoded part of an extensin polypeptide. Forty positive phage plaques were identified, and were extensively plaque-purified. ~he isolated clones were then re-screened under high stringency conditions (O.l x SSC, 0.1% SDS at 65C), when only one phage clone gave continued strong hybridisation to the cDNA probe. This clone, lambdaB3l, was selected for further study.
DNA from the selected phage was isolated and characterised by restriction and Southern blotting, using pRRt566 as a probe. The restriction map of lambdaB3l obtained is shown in Fig. 2, and shows that the clone contains an insert of 12.7 kb. The region of DNA
hybridising to the cDNA probe was localised to a fragment of 1.0 kb (Nsi I-Pst I) adjacent to the left arm of the vector.
To further characterise the gene present on this clone, restriction with Dde I and Rsa I was carried out, followed by Southern blotting and probing with the cD~A as before.
These two enzymes were chosen because they restrict the homologous cDNA sequences at multiple sites, corresponding ' ' : , ~ ', :
: : , - : .: ' ' . ~ . . ' . ' . '" ' " ~' ' '.
-: . , ~ . ' WO91/1~992 PCT/GB91/00416 . , ~,, . ~
2 ~7~32 7 to the repeats in the coding sequence, and also generate unique diagnostic fragments from the 3' non-coding region of the sequence. Although the genomic clone contained the 84 bp restriction fragments generated from the region of pRRt566 encoding the 28 amino acid repeat sequences, the diagnostic fragments specific to pRRt566 were not present, suggesting that the gene present was not identical to the cDNA. DNAs from a further ten phage clones were purified and similarly screened; however, none of the clones contained diagnostic fragments identical to pRRt566 and were not considered further in the present study.
To further characterise the gene present on lambdaB31, a Southern blot of insert DNA was hybridised with a probe prepared from a second rape root extensin cDNA
clone, pRRt592; this probe contained only 39 bp of sequence identified as encoding a putative leader sequence of an extensin precursor polypeptide and hybridised to the same 1.0 kb fragment as was detected by the pRRt566 probe. A 3' flanking sequence prc~e from pRRt566 was prepared by subcloning a Hinc II-EcoRI fragment into pUC 18. This probe contained no coding sequence, which hybridises very strongly due to its G-C rich nucleotide composition. The 3' probe failed to hybridise to lambdaB31 DNA suggesting that thls clone contained the 5' end and coding sequence of an extensin gene, but either lacked the 3' flanking sequence, or was divergent in the 3' flanking region.
When the 1.0 kb fragment of lambdaB31 was labelled and used as a probe on Southern blots of restricted rape genomic DNA, similar results (not shown) to those o~tained when pRRt566 was used as a probe, were obtained. A 1.85 kb Hinc II fragment of genomic DNA which was present at 1 copy per haploid genome, corresponded to the expected Hinc II
fragment predicted from the lambdaB31 restriction map.
Se~uence of extensin aene extA
Approximately 2.7 kb of DNA sequence of the genomic . . .
: ' :
WO9l/l3992 PCT/GB91/00416 2 ~7 ~ 3 2 1 - 12 -clone lambdaB31 was fully determined. The 5.3kb HindIII-AvaI fragment from lambdaB31 was subcloned into pUC18 (Yanisch-Perron et al, Gene 33, 103-119, 1985) to give pRlambdaS4 (Figures 2 and 3) from which the 2.7kb HincII-HincII fragment was sequenced (Figure 2). The sequencing map for this region is shown in Fig. 2, and the complete determined sequence is given in Fig. 1. The sequence contains an open reading frame predicting a polypeptide of 299 residues. The first 23 residues of the sequence encode a leader sequence, when compared with other extensin sequences and as defined by the rules of von Heijne (1985, J. Mol. Biol. 184, 99-105). The remainder of the I coding sequence encodes a highly proline-rich polypeptide of 276 amino acids.
The promoter of the invention is the 5' flanking sequence of the extA gene as shown in Figure 1. This sequence contains a sequence (CTATATAAA) closely homologous to the consensus "TATA" ~ox for plants seventy-four bases 5' to the initiation codon. Apart from this no significant features can be recognised. Comparison of this 5' flanking sequence with that of the carrot extensin gene pDC5Al (Chen and Varner, EMBO J. 4, 2145-2151, 1985) reveals no strongly conserved sequence regions, apart from the "TATA" box.
Expression of extA
To confirm that extA represents an expressed gene, and to determine its transcription start, a series of Sl mapping experiments were carried out. Fragments of extA 5' t~` end-labelled at a Dde I site (base 71) and extending in a 5' direction to the Nsi I site (base -74) or the Dde I site (base -237) were isolated and hybridised to poly(A)+RNA from rape roots. ~fter treatment with Sl nuclease, the protEcted fragments were sized by polyacrylamide gel electrophoresis.
In bo~h cases, protected fragments of 66-75 bases were obtai~ed with the strongest band corresponding to the underlined base in the sequence TAAGAGC_TCAAAC, which was .' ' : .. . .- - . ,, ,. , . . - , :
: ...... . . . . .
. ~ ~ . . , , . . ' ; ' . :
. ' ; ' . . : . ' ' : , . .: .:
W 0 91/13992 PCr/CB91/00416 ,~`' - 13 - 2~7~327 designated base +l (indiated in Figure 1 by T^S). This sequence is in good agreement with the consensus transcription start in plants, -CATC- and is at a congruous distance from the "TATA" box (34 bases). No other protected fragments that were not also present in the controls were observed. A further probe, labelled at the Nde I site at base -86 and extending to the Nde I site at base -453, was prepared and hybridises as above. No protected fragments of this probe were observed, although a small amount of intact probe was present in both the experimental and control hybridisations. These results suggest that the determined transcription start is the only start site in extA, in contrast to the carrot extensin gene where two transcription start points were observed.
To confirm the above conclusions, and to investigate the organ-specificity of expression of extA, fragments of the gene were used as probes on Northern blots of RNA from different rape organs. A probe consisting of the complete coding sequence of the gene, and extending to base -74, was hybridised to RNA from four rape organs: root, green leaf, etiolated leaf and developing seed. This probe hybridised to two mRNA species in root, of approx. 1300 and 1480 bases, and hybridised only very weakly to a mRNA
species in developing seeds, of approx. 1600 bases. This hybridisation pattern is very similar to that given by the cDNA species pRRt556 (and closely homologous species), and rehybridisation of the same blot to the cDNA probe confirmed that the same bands were detected by both probes. If the size of 3' flanking sequence of pRRt566 is added to that of the sequence of extA, the completed gene would be predicted to produce an mRNA species of approx. 1250 bases, assuming a poly(A) tail of 30-bases is added to the cDNA sequence. The observed mRNA species of approx. 1260 bases in rape roots can ~herefore be suggested to be the product of extA. A
very low level of hybridisation of the extA probe to a large mRNA species (approx. 4.6 kb) pres~nt in root was also ' . ` ' . ... . , , , .. . . , : ..
,. . : -:
~ 3~ - 14 -observed.
EXAMPLE 2: Expression of the extA_in_Transgenic Tobacco The original rape extA gene as isolated from the lambdaB31 clone lacked a 3' terminator region due to the cloning strategy used (Figure 4). Accordingly, a 260bp nopaline synthase (nos) BamHI-EcoRI fragment which contains an efficient plant terminator sequence was excised from the clone pNOP-NEO and ligated into BamHI-EcoRI cut pUC18 and cloned in E. coli DH5h. pNOP-NEO is a clone containing -the NOS promoter linked to the Neomycin Phosphotransferase (NPT) gene which encodes kanamycin resistance, linked to the NOS terminator as published by Bevan, Nucleic Acids Research 2, 8711-8721 (1984).
The extA gene, excised from pRlambdaS4 on a 4.75kb HindIII-SalI fragment, was then ligated into the NOS
terminator pUC18 clone, also restricted with HindIII-SalI, and cloned in E. coli DH5~. The final extA - NOS terminator construct is shown in Figure 5. The whole extA - NOS
terminator construct was then excised on an intact 5.01kb HindIII-EcoRI fragment and ligated into the binary vector pBIN19 (Bevan, 1984) restricted with HindIII-EcoRI, and cloned into E. coli MC1022. The final hybrid gene construct designated pBINl9:extA is shown in Figure 6 and contains additionally the endogenous kanamycin resistance gene (NPT) located between the T-DNA borders.
, This construct termed pBINl9:extA was triparentally t ~ mated into A. tumefaciens LBA4404 and used to transform leaf discs of Nicotiana tabacum (SRl). Prior to tobacco being ' used as a test transgenic system, Southern blotting experiments were performed on tobacco DNA to show that , hybridisation of extensin coding region to tobacco DNA did ; not occur. Even at low stringency no hybridisation of the extensin coding region to tobacco DNA could be seen. In detail:
~, ,-, ~
:- :: : . . . . . .
. .. .. . . . . .. . .
. ... . - , .. ,, . . , : , :
~: : . , . .. , . : . . . .
WO9l/l~992 PCT/GB91/00416 2~7~327 Bacterial strains and coniuqations The vector plasmid pBIN19 in Escherichia collstrain MC1022 (Bevan, Nucl. Acids Res. 12, 8711-~721, 1984), the mobilising E. coli strain HB101/pRK2013 (Ditta et ai, PNAS USA 77, 7347-7351, 1980) and the host Aarobacterium tumefaciens strain LBA4404/pAL4404 (Hoekema et al, Nature 303, 179-180, 1983) were used. For bacterial conjugation antibiotics were used at the following concentrations:
kanamycin acid sulphate, 50~g.ml 1 (kan); rifampicin, lOO~g.ml 1 (rif~; streptomycin sulphate, 500 ~g.ml 1 (strep). The recombinant vector BINl9:ext A was mobilized in a triparental mating by mixing 200~1 each of overnight cultures of E. coli MC1022/BIN19 (kanR, strepS, rifS), E.
coli HB101/pRK2013 (kanR, strepS, rifS) and A. tumefaciens LBA4404 (kanS, strepR, rifR), and incubating at 27C on a L3 plate without antibiotic selection for 15h. The cell mixture was then diluted with 10 mM MgS04; plated out on minimal medium containing kanamycin and incubated at 27C
.or 4 days. The A. tumefaciens LBA4404 colonies were checked for the correct antibiotics resistance markers (kanR, strepR, rifR), and further analysed by colony hybridisation and Southern analysis to confirm that the nPt and ext A genes were present in an intact, unrearranged form in the BINl9:ext A plasmid.
~ .
Tobacco transformation and reqeneration Agrobacterium tumefaciens LBA4404/pBINl9:ext A was cultured in LB medium containing 20~g.ml 1 kanamycin at 27C, the bacteria were pelleted, washed three times in 2 m~
MgS04, and resuspended in MS salts (Flow Labs., Rickmansworth, Herts., UK), lOmg.ml 1 sucrose (pH 5.8) at a density of approx 109 cells.ml 1.
Expanded leaves from well-watered N. tabacum (SRl) plants were surface-sterilized with 70~ (v/v) ethanol (30 s) followed by 5% (w/v) Ca(OCl)2 (15 min). After washing in sterile water, each leaf was cut into squares (approx. 8 x ., :
:, .
.. . . . . . . . .
.:
.. . .
, ,. . .: .- . . . : ..
.-.,. : . , :
.: . . ~ . ,:
WO91/13~92 PCT/GB9t/004t6 m~2) avoiding major veins and then placed in the bacterial suspension, which was intermittently agitated to wet the cut leaf-edges. After 10-15 min. incubation (22-25C) the leaf pleces were placed (adaxial surface upwards on agar plates of shoot-induction medium, comprising MS salts (including vitamins), 10 mg.ml 1 sucrose, 2 ~g.ml 1 N~
furfurylaminopurine (kinetin), 0.2 ~g/ml 1 1-naphthylacetic acid (pH 5.8) and 8 mg.ml 1 bacto-agar, and cultured at 25C, 18-h photoperiod (120~mol.m 2.s 1 PAR). After 2 days the leaf pieces were transferred to liquid shoot-ir,duction medium containing 1 mg.ml 1 carbenicillin (disodium salt) and gently agitated (60 rpm shaker) overnight. The leaf pieces were surface-dried on sterile absorbant paper and placed on agar plates of shoot-induction medium containing 500 ~g.ml 1 carbenicillin, 200 ~g.ml 1 kanamycin (acid sulphate) and cultured under the conditions described above.
Shootlets which developed from the cut edges of the leaf explants (four to six weeks from inoculation) were excised and transferred to agar plates of half-strength MS
salts, 5 mg.ml 1 sucrose, 250 ~g.ml 1 carbenicillin, 200 ~g.ml 1 kanamycin (pH 5.8). The shootlets which continued to expand were transferred to 60-ml sterile vessels (Sterilin, Feltham, Middlesex, UK) containing root-induction medium comprising half-strength MS salts, lOO~g.ml 1 carbenicillin, lOO~g.ml 1 kanamycin and 8 mg.ml 1 agar.
Shootlets which developed roots were transferred to 250-ml sterile glass jars containing half-strength MS salts, 50 ~g.ml 1 carbenicillin and 8 mg.ml 1 agar. When the plantlets had developed an extensive root system, they were removed from culture and potted in 1:1 Levington compost:perlite (Silvaperl Products, Harrogate, UK), and grown in a controlled environment with daily watering.
Tissues from the transgenic plants were harvested into liquid air for extraction of DNA, for genomic analysis to assess the integrity of the transferred gene, and RNA, for analyses of extensin gene expression. The potted plants ' WO91/13992 PCT/Gn91/004~6 ?`~ " 2 ~ 7 8 3 2 7 flowered after about five weeks, and following self-pollination, the seeds from each plant were collected at dehiscence.
Extraction of DNA and Southern Analvsis The DNA from N. tabacum leaves was extracted and purified. The DNA probes for hybridization were 32P-labelled to high specific activities (>8 x 1011 Bq.~g 1) using random priming according to Feinberg and Vogelstein (Anal. Biochem. 132, 6-13, 1983). Standard techniques were used for Southern transfer and hybridization and high stringency (30 mM NaCl, 3 mM Na3 citrate, 65C, 60 min) was employed in the final post-hybridization wash. Filters were autoradiograhed for 72 h at 80C using flashed X-ray film (Fujimex, Swindon, UK) and intensifying screens (Du Pont, Stevenage, UK).
Extraction of RNA and Northern AnalYsis Total RNAs from tissues of the transgenic N.
tabacum plants were isolated by the procedure of Logemann et al. (Anal. Biochell. 163, 16-20, 1987). To estimate the size of RNAs specifically hybridizing to the rape extensin probe, 10~g of each sample RNA was glyoxalated, run on agarose -- gels, and transferred to nitrocellulose. Northern blots were washed to high stringency (15 mM NaCl, 1.5 mM Na3 ` citrate, 0.1~ sodium dodecyl sulphate (SDS), 25 min, 50C), and the filters autoradiographed for 2 weeks as described above.
Fifteen transgenic tobacco plants were regenerated i and grown from the initial transformation experiment.
Samples of leaf and root were collected for analyses by Southern and Northern blotting. The majority of the transgenic plants regenerated contained intact, unrearranged copies of the introduced hybrid extensin gene. Estimates of the copy number of the introduced gene in the various independent transformants varied from one copy to five - copies. Only trans~enic tobacco plants containing intact, unrearranged copies of the introduced gene were used for , .,:
,, .
- , , - ., , : ~ , .
-.
- : : , , ,: ~ . :
~ , . , ~-, ' .: . . . . .. .
.
WO91/1399~ PCT/GB9l/00416 ~7832~ ~
further analysis of extensin expression.
Because of the lack of availability of specific rape extensin antibodies, Northern hybridisations were performed on total RNA extracted from tobacco leaf and root tissues, using the extensin l.0 kb coding sequence from the genomic clone lambdaB31 as a probe. No hybridisation to leaf RNA from either control or transformed tobacco plants was seen. Hybridisation of the extensin probe to transgenic root RNA was seen in all the transformants tested, although the level of hybridisation between individual transformants varied (position effect).
Seeds were collected from the initial batch of transformed tobacco, and were sown in compost. Plants were grown from this seed.
EXAMPLE 3: Expression of Glucuronidase Enzyme under Control of the Rape Promoter In order to see the expression of the rape gene extA in rape, the rape promoter from lambdaB31 was fused in a translational fusion to the coding sequence of the glucuronidase (GUS) gene in a binary vector variant of 8IN19. The clone containing the construct was mated with an Aarobacterium strain (LBA 9402) containing an oncogenic Ri plasmid, pRi 1885 (Constantino et al, Plasmid 5, 170-182, 1981). Inoculation of this strain into rape seedlings produces transgenic hairy roots, which are then easily assayable for GUS activity. Whole plants can be regenerated from excised transgenic hairy roots.
In detail, the rape extensin promoter was excised from pRlambdaS4 as a l.Okb HaeIII-HaeIII fragment. This fragment was blunt-end ligated into a modified pBINl9 binary vector, pBIlOl containing a promoterless glucuronidase (GUS) gene, restricted with SmaI at the start of the GUS coding sequence (see Jefferson, Plant Molecular Biology Reporter 5, 387-40S, 1987) (Figure 8). The rape promoter expression .~ from this translational fusion will give a glucuronidase : ` ~
., ~ .
'I
, - , : ~ , . .. ~ .
. ~ . , . . . :
, . . .
- . . ,.; ; , . : .: , -., ~ , ~ . , . :
WO91/13992 PCT/GBgl/00416 2~7~327 enzyme with either 7 or 11 extra amino acids at the N-terminus, depending on which rape ATG is used as the translation initiation codon.
The extA-GUS hybrid gene in pBI101 (pBIlOl:extA-GUS) was cloned in E. coli MC1022 and then transferred into Aarobacterium tumefaciens or Aqrobacterium rhizogenes by tri-parental matings with the appropriate Agrobacterium strains. Preliminary results to test for expression from this construct, using the X-Gluc (5-bromo~4-chloro-3-indolyl-~-D-glucuronide) histochemical assay of Jefferson (Plant Molecular Biology Reporter 5, 387-405, 1987) in rape 'hairy roots' transformed with Aarobacterium rhizoqenes containing pBIlOl:extA-GUS, have clearly shown that the promoter is active in rape root tissue.
Ra~e Tissue culture and transformation ~rotocols:
Transformation experiments usina A. rhizoqenes Axenically growing seedlings of B. na~us cv.
Bienvenue (winter rape), Brutor and Rapid Cycling were inoculated at their cotyledonary nodes with an A. rhizoqenes LBA9402 strain carrying both the Ri plasmid pRi 1855 (Constantino et al, 1981) and the kanamycin resistance fusion construct of Figure 8 (pBIlOl:extA-GUS) as separate independent replicons. Hairy roots arising from the site of inoculation can be excised and grown in a culture medium (1 x MS salts and vitamins, 4% sucrose, 2 g/l CaC12.H20, 0.1 mg/1 NAA, 2.5 mg/l BAP) 0.1 mg/l thiamine, 200 mg/l cephotaxime, 50-mg/1 kanamycin, 8 g/l Bacto Difco agar, pH
5.8, to proliferate the hairy roots.
Regeneration can be achieved as follows: 0.5 cm sections of the terminal 2 - 3 cm of hairy roots are excised, treated with 2,4 - D at a concentration of 3 mg/l, and plated on shooting medium containing kanamycin at 50 mg/l to select for tissues which contained the T-DNA
kanamycin gene of the fusion construct of Figure 8. Shoots arising from these hairy roots are excised and grown on medium F of Pelletier et al (Mol. Gen. Genet. 191, 244-250 ~. ' ~ ' .
~,~., ' .
.`
~ ' , ' ' ' ' ' ~ ~', . . .
WO91/1399' PCr/GB91/00416 ~, ,-%~32~ - 20 -(1983)) for 2-3 weeks. They are then transferred to rooting medium G, and when a sufficient root system has developed they are transferred to soil and grown to maturity in a containment growth room.
Transgenic winter rape plants are vernalised to induce flowering by growing them at 4C with a 8h daylight period. Flowers are emasculated before anthesis and outcrossed with wild type rape pollen. Seeds obtained after pod set are collected, sown in soil and the progeny plants grown to maturity. The progeny plants are initially scored visually with regard to the degree of the hairy root syndrome being exhibited. Kanamycin resistance in the leaves of the progeny is assayed by transferrlng leaf discs to callus inducing media (see below) containing kanamycin at ; either 50 or 150 mg/l. Both the Ri and the kanamycin resistance traits can be further confirmed by Southern -~ hybridisation analysis.
The media used in the Examples are:
Media 1. For seedlina arowth MS salts 2.355 g/l Sucrose 20 g/l Difco Bacto agar 15 g/l pH
5.8 2. For Aarobacterium rhizoaenes liauld culture - YMB
~ Mannitol 10 g/l ,; Yeast extract 0.4 g/l KH2P04 0.5 g/l MgS4 2H2 0.2 g/l NaCl 0.1 g/l Kanamycin 50 mg/lpH 7.0 , 3. For hairv root culture (Ooms' medium: Ooms et al (1985) Theor. Appl. Genet. 71, 325-329) '.
, , . -- .
,: .
.~.
.. , , ~. .
:, -. ,; , ::, . . :: . . . : ., PCr/~B91/00416 2~178327 MS salts 4.71 g/l CaC12.2H20 2 g/l Sucrose 40 g/l NAA 0.18 mg/l BAP 2.5 mg/l Thiamine HCl 0.1 mg/l Difco Bacto agar 8 g/l Xanamycin 25 or 50 mg/l Cephotaxime 200 mg/l pH 5.8 4. For shoot induction, multi~lication and rootina D solution, RCC medium, F and G media are as described by Pelletier et al. (1983) and Guerche et al.
(Mol. Gen. Genet. 206, 382-386, 1987). In addition, a level of Cephotaxime of 200 mg/l is maintained in all these media at all times. ~
The present invention relates to a plant promoter.
Extensin is the best characterised structural protein in the walls of plant cells (Cassab and Varner, Ann.
Rev. Plant Physiol. 39, 321-353, 1988). It is a member of a class of highly basic, hydroxyproline-rich glycoproteins present in a wide variety of plants. Extensin has been reported to be present at greatest abundance in sclerenchyma tissues and a variety of functional roles have been ascribed to the protein, including mechanical strengthening and organisation of the cell wall. Extensins vary in their ~ -primary structure in different plants, organs and tissues.
In some cases, there are two different extensins within the same tissue or cell type, which may be function-related.
As part of a programme to isolate plant genes expressed in an organ-specific manner, mRNA species present in the roots of oilseed rape (Brassica napus L.) were investigated, with the aim of isolating se~uences abundant in root but not in other tissues. A family of cross-hybridising sequences present at highly enhanced levels in root has been isolated, characterised, and shown to encode proteins homologous to extensin. This has enabled us to identify a promoter capable of directing the expression of proteins in roots.
Accordingly, the present invention provides a promoter which is capable of directing protein expression in roots of plants and which has:
(a) the seguence from nucleotide -1616 to nucleotide -1 shown in ~igure 1 or a part of the said sequence or ; (b) a said sequence (a) modified by one or more nucleotide substitutions, insertions and/or deletions and/or by an extension at either or each end.
The invention also provides a DNA fragment comprisin~ such a promoter operably linked to a gene, i : - , :: . : . . . .
: . .- . -. .. . :
. . -,: . . : ~ , . :...... ~ . :
- , "
. , . : . , . .: :
2~78327 ~
typically a heterologous gene encoding a protein.
Additionally provided is a vector which comprises a gene encoding a protein under the control of a promoter as above such that the gene is capable of being expressed in a plant cell transformed with the vector. A suitable vector is one in which the promoter is fused directly to the 5'-end of the gene. The vector may further contain a region which enables the gene and the promoter to be transferred to and stably integrated in a plant cell genome. The vector is generally a plasmid.
Plant cells can be transformed with such a vector.
The invention therefore further provides plant cells which harbour a promoter as above operably linked to a gene encoding a protein. Transgenic plants may be regenerated from such plant cells. A transgenic plant can be obtained which harbours in its cells a promoter as above operably linked to a gene encoding a protein. Seed may be obtained from the transgenic plants. Plants may in turn be grown from this seed.
The invention additionally provides a method of producing a transgenic plant capable of producing a desired protein in the roots of the plant, which method comprises:
(i) transforming a plant cell with a vector according to the invention, the protein encoded by the gene under the control of the said promoter being the desired protein; and (ii) regenerating plants from the transformed cells.
In the accompanying drawings:
Figure l shows the nucleotide sequence of gene extA, with the predicted amino acid sequence of the rape extensin polypeptide, and the sequence of the promoter of the invention from nucleotide -1616 to nucleotide -l. The complete sequence is the sequence of the 2.7kb HincII-HincII
fragment shown in Figure 2. The predicted site of cleavage of the leader sequence is indicated by a colon (:). The ~: , , .: , . . , - :
: - . . - . . : . ~ -: . .
. . , . . .. ~ : :
,. . . . ..
. ~ .: .
.. . . . .
. . . : : . .. . : ... . ~ . ~
WO91/t3992 PCT/GB91/00416 ~ 2978327 transcription start point is indicated by a circumflex (T^S), and a sequence similar to the consensus "TATA"
control box is also indicated. Other sequence features are as indicated on the Figure.
Figure 2 is a restriction map of the oilseed rape genomic clone lambdaB31 (12.7 kb) encoding gene extA, a restriction map of pRlambdaS4, a HindIII-AvaI fragment from lambdaB31 in pUC18, and a sequencing map of the 2.7kb HincII-HincII fragment containing extA. ra and la, indicate right arm and left arm of the EMBL 3 lambda vector, respectively; ~ \ \\\~ indicates coding sequence.
Sa/H2-Al/Sm/Xl fragment is a part of EMBL 3. Key to restriction site symbols on sequencing map: Sa, Sal I; H3, Hind III; Sm, SmaI; H2, Hinc II; Pl, Pst I; AI, AvaI; XI, Xma I; Ns, Nsi I; RI, Rsa I; Ha, Hae III; Ss, Ssp I; Nd, Nde I; Pv, Pvu II.
Figure 3 shows a detailed restriction map of pRlambdaS4, a sub-clone from ~B31 comprising a HindIII-AvaI
fragm~nt of lambdaB31 in pUC18.~ shows the location and direction of transcription of the extensin coding sequence.
There are no sites in the insert for PvuI, XhoI, BscI, BamHI, BglII and EcoRV.
Figure 4 shows a simplified restriction map of the sub-clone pRlambdaS4;~ indicates the position of the extensin coding sequence andl lindicates the region containing the promoter conferring root expression.
Figure 5 is a map of the hybrid gene employed in Example 2; ~ indicates the nopaline synthase (NOS) terminator.
Figure 6 is a map of the hybrid gene from Figure 5 in the vector BIN 19.
Figure 7 shows the rape extensin promoter on a HaeIII fragment excised from lambdaB3I, as described in Exampl~ 3.
Figure 8 shows the fusion construct comprising the rape extensin promoter and the glucuronidase gene coding ..
'; , ' ', '' ' 2~783`%~
sequence, prepared in Example 3.
The full length promoter of the invention is composed of the sequence upstream of the oilseed rape extA
gene, from nucleotide -1616 to nucleotide -1 in Figure 1, base 1 being the adenine (~) base of the CAT transcriptional start codon for the extA gene. The promoter may be obtained from a clone, lambdaB31 by excision on a 4.5kb HindIII-AvaI
fragment (Figure 3). Clone lambdaB31 was obtained from a genomic library prepared from oilseed rape (Brassica naPus L). The HindIII-AvaI fragment was subcloned in pUC18 as pRlambdaS4 from which the promoter can be excised as a 0.96kb HaeIII fragment. E. coli D~5~ harbouring pRlambdaS4 and bacteriophase lambdaB31 have been deposited at the National Collection of Industrial and Marine Bacteria, Aberdeen, GB on 8 March 1990 under accession numbers NCIMB
40265 and NCIMB 40266.
A part of the full length sequence from nucleotide -1616 to nucleotide -1 and modified forms of the full length or part sequence are alternative promoters according to the invention. The full length or part promoter sequence may be modified by one or more nucleotide-substitutions, insertions -and/or deletions and/or by an extension at either or both ends. Any part or modified promoter sequence must however still be capable of acting as a promoter in the roots of plants. When the full length sequence or a part of the full length sequence, i.e. an unmodified sequence, is modified typically there is a degree of homology of at least 60 between a modified sequence and the unmodified natural sequence. The degree of homology may be at least 75~, at least 85~ or at least 95%.
A part of the full length promoter sequence may be obtained by use of restriction endonucleases and/or exonucleases. The promoter may be obtained as a 0.96 kb fragment by treating the sequence shown in Figure 1 with HaeIII. A modified sequence may be obtained by introducing changes into an unmodified promoter sequence. This may be .~
.,, - :
. : . . . . .. :
: . . . . . .
. .. . . : . . : .. . . , ~ : ... :
: .. . .. .
WO9l/13992 PCT/GB91/OW16 ~ 2~783~7 achieved by any appropriate technique, including restriction of the natural sequence with an endonuclease, insertion of oligonucleotide linker adapters, use of an exonuclease and/or a polymerase and site-directed mutagenesis.
Whether a part of the full length promoter sequence or a modified sequence is capable of acting as a promoter may be readily ascertained by experiment. The putative promoter sequence is fused to the glucuronidase coding sequence in the plomoter-less binary vector pBI101 at the SmaI site as described in Example 3. Following the procedure of Example 3, expression of glucuronidase is investigated in the transgenic hairy roots produced.
The promoter may be operably linked to a gene, typically a heterologous gene, encoding a protein. The heterologous gene may encode any protein it is desired to express. "Heterologous" means that the gene is not naturally operably linked to the promoter, i.e. a heterologous gene is not the oilseed rape extA gene. The protein may additionally comprise a transit peptide sequence at its N-terminus, encoded within the "heterologous" gene sequence.
The prom~ter is typically used to express proteins in the roots of plants. The protein whose expression is controlled by the promoter may be for example a protein conferring biological control of pests or pathogens, in particular pests or pathogens to which the roots of plants are susceptible.
The promoter sequence may be fused directly to a gene or via a linker. The linker sequence may comprise an intron. Excluding the length of any intron sequence, the linker may be composed of up to 4S bases, for example up to 30 or up to 15 bases.
DNA fragments and vectors can be prepared in which the promoter is operably linked to a gene, typically a heterologous gene. The fragments and vectors may be single or double stranded. Plant cells can be transformed by such . ,: . . :
.
:
~ , . , ' ... . ~ .
WO91~1~992 PCT/GB91/00416 2~32~ - 6 -fragment by direct DNA uptake, or by way of such a vector.
The vector incorporates the gene under the control of the promoter. The vector contains regulatory elements capable of enabling the gene to be expressed in a plant cell transformed with the vector. Such regulatory elements include, besides the promoter, translational initiation and/or termination sequences. The vector typically also contains a region which enables the gene and associated regulatory control elements to be transferred to and be stably integrated in the plant cell genome.
The vector is therefore typically provided with transcriptional regulatory sequences and/or, if not present at the 3'-end of the coding sequence of the gene, a stop codon. A DNA fragment may therefore also incorporate a terminator sequence and other sequences which are capable of enabling the gene to be expressed in plant cells. An enhancer or other element able to increase or decrease levels of expression obtained in particular parts of a plant or under certain conditions may be provided in the DNA
fragment and/or vector. The vector is also typically provided with an antibiotic resistance gene which confers resistance on transformed plant cells, allowing transformed cells, tissues and plants to be selected by growth on appropriate media containing the antibiotic.
Transformed cells are selected by growth in an appropriate medium. Plant tissue can therefore be obtained comprising a plant cell which harbours the gene under the control of the promoter , for example in the plant cell genome. The gene is therefore expressible in the plant cell. Plants can then be regenerated which include the gene and the promoter in their cells, for example integrated in the plant cell genome, such that the gene can be expressed.
The regenerated plants can be reproduced and, for example, seed obtained. Root-specific expression of proteins can therefore be directed by the present promoter in plants.
Alternatively, transformed roots may be grown in culture for ' ,~
. .
-. , . ;, , ~; ~ ,. . .
: , . .. . , . , : -: .
WO 91/13992 PCI/GP~9~ 416 ~ 2~7~327 the purposes of production of proteins, especially plant proteins.
A preferred way of transforming a plant cell is to use Aqrobacterium tumefaciens containing a vector comprising the promoter operably linked to the gene encoding a protein it is wished to express. A hybrid plasmid vector may therefore be employed which comprises:
(a) the gene under the control of the promoter and other regulatory elements capable of enabling the gene to be expressed when integrated in the genome of a plant cell;
(b) at least one DNA sequence which delineates the DNA to be integrated into the plant genome; and (c) a DNA sequence which enables this DNA to be transferred to the plant genome.
Typically the DNA to be integrated into the plant cell genome is delineated by the T-DNA border sequences of a Ti-plasmid. If only one border sequence is present, it is preferably the right border sequence. The DNA sequence which enables the DNA to be transferrec to the plant cell genome is generally the virulence (vir) region of a Ti-plasmid.
The gene and its transcriptional and translational control elements, including the promoter, can therefore be provided between the T-DNA borders of a Ti-plasmid. The plasmid may be a disarmed Ti-plasmid from which the genes for tumorigenicity have been deleted. The gene and its transcriptional and control elements, including the promoter, can, however, be provided between T-DNA borders in a binary vector ln trans with a Ti-plasmid with a vir region. Such a binary vector therefore comprises:
(a) the gene under the control o~ the promoter and other regulatory elements capable of enabling the gene to be expressed when integrated in the genome of a plant cell; and (b) at least one DNA sequence which delineates the DNA to be integrated into the plant genome.
Aarobacterium tumefaciens, therefore, containing a ,. . . . .
, , .
, :, -,:, ' ' ' . , , .. . ~ , . . .
WO91/13g92 PCT/GB91/00416 2~7~27 ~, hybrid plasmid vector or a binary vector ln trans wlth a Ti-plasmid possessing a vir region can be used to transform plant cells. Tissue explants such as stems or leaf discs may be inoculated with the bacterium. Alternatively, the bacterium may be co-cultured with regenerating plant protoplasts. Plant protoplasts may also be transformed by direct introduction of DNA fragments which encode the gene of interest and in which the promoter and appropriate other transcriptional and translational control elements are present or of a vector incorporating such a fragment.
Direct introduction may be achieved using electroporation, polyethylene glycol, microinjection or particle bombardment.
Plant cells from monocotyledonous or dicotyledonous plants can be transformed according to the present invention. Monocotyledonous species include barley, wheat, maize and rice. Dicotyledonous species include tobacco, tomato, sunflower, petunia, cotton, sugarbeet, potato, lettuce, melon, soybean, canola (rapeseed) and poplars.
Tissue cultures of transformed plant cells are propagated to regenerate differentiated transformed whole plants. The transformed plant cells may be cultured on a suitable medium, preferably a selectable growth medium. Plants may be regenerated from the resulting callus. Transgenic plants are thereby obtained whose cells harbour the promoter operably linked to the gene encoding the protein it is wished to express, for example integrated in their genome.
The gene is consequently expressible in the cells. Seed from the regenerated plants can be collected for future use, and plants grown from this seed.
The following Examples illustrate the invention.
1. A family of cross-hybridising cDNA clones was isolated from a cDNA library produced with poly (A) +RNA from the roots of oilseed rape (Brassica naDus L.). The clones were selected as abundantly expressed in root by differential screening of the root CDNA library with cDNA
- ., :, , , . .' :: ;,: ~......... , :' : :
. . ; .
~ ~ ! 2 ~ 7 8 ~ 2 7 g probes prepared from root, green leaf, etiolated leaf and developing seed. mRNA species corresponding to the selected abundant clones were expressed in roots at levels of at least 400 x those in other organs, as shown by Northern blot analysis and RNase protection assays. One of the cDNA
clones was designated pRRt566.
2. An extensin gene designated extA, was obtained from an oilseed rape (Brassica naPus L.) genomic library screened with pRRt566 at high stringency. The gene is a mem~er of a multigene family, consisting of about three members per haploid genome with strong homology to the probe, and a further twenty or so members of weaker homology. The isolated gene, although not identical to the cDNA probe, was also found to be specifically expressed in roots, and was transcribed into a mRNA species of approximately 1300 nucleotides in size. A single transcription start was identified by Sl mapping. A complete nucleotide sequence of the extA gene and its flanking regions was determined. This enabled the gene promoter to be identified. In more de:ail:
Identification of extensln qenes in qenomic DNA
The cDNA species from rape root, pRRt566, previously identified as encoding a protein homologous to extensin, was used as a probe on Southern blots of restrictions of rape genomic DNA. The insert of pRRt566 hybridised to a large number of genomic fragments in all restriction digests, but the strength of hybridisation to all fragments was not equal; 1-2 fragments in all di~ests hybridised at an intensity at least five times that of the other bands. Copy number reconstructions indicated that the strong bands corresponded to approx. 2-3 gene copies per haploid genome: the patterns can be consistently interpreted to give a total of 3 genes per genome highly homologous to this probe. The weakly hybridising fragments were present at less than one estimated copy per haploid genome, and must therefore represent genes that are only partly homologous to the extensin probe. The total sequences detected by this : :
~'091/13992 PCT/GB91/00416 2~7~327 - 10 - ~
probe make up a large multigene family, of which three genes, determined to be closely homologous to pRRt566, form a sub-family. In confirmation of these conclusions, when a 3' flanking sequence probe (240 bp) was prepared from pRRt566, and hybridised to genomic blots as above, hybridisation of this probe to the strongly hybridising bands was identical to that using the whole cDNA insert as a probe, except hybridisation to the pRRt566 weakly hybridising bands was largely eliminated.
Isolation and characterisation of a genomic clone containinq an extensin aene An oilseed rape genomic library, constructed by inserting random Sau 3A fragments of genomic DNA, into lambda EMBL3, was screened at low stringency with a probe prepared from the insert of pRRt566. This cDNA clone was isolated from a library prepared from rape root mRNA, and encoded part of an extensin polypeptide. Forty positive phage plaques were identified, and were extensively plaque-purified. ~he isolated clones were then re-screened under high stringency conditions (O.l x SSC, 0.1% SDS at 65C), when only one phage clone gave continued strong hybridisation to the cDNA probe. This clone, lambdaB3l, was selected for further study.
DNA from the selected phage was isolated and characterised by restriction and Southern blotting, using pRRt566 as a probe. The restriction map of lambdaB3l obtained is shown in Fig. 2, and shows that the clone contains an insert of 12.7 kb. The region of DNA
hybridising to the cDNA probe was localised to a fragment of 1.0 kb (Nsi I-Pst I) adjacent to the left arm of the vector.
To further characterise the gene present on this clone, restriction with Dde I and Rsa I was carried out, followed by Southern blotting and probing with the cD~A as before.
These two enzymes were chosen because they restrict the homologous cDNA sequences at multiple sites, corresponding ' ' : , ~ ', :
: : , - : .: ' ' . ~ . . ' . ' . '" ' " ~' ' '.
-: . , ~ . ' WO91/1~992 PCT/GB91/00416 . , ~,, . ~
2 ~7~32 7 to the repeats in the coding sequence, and also generate unique diagnostic fragments from the 3' non-coding region of the sequence. Although the genomic clone contained the 84 bp restriction fragments generated from the region of pRRt566 encoding the 28 amino acid repeat sequences, the diagnostic fragments specific to pRRt566 were not present, suggesting that the gene present was not identical to the cDNA. DNAs from a further ten phage clones were purified and similarly screened; however, none of the clones contained diagnostic fragments identical to pRRt566 and were not considered further in the present study.
To further characterise the gene present on lambdaB31, a Southern blot of insert DNA was hybridised with a probe prepared from a second rape root extensin cDNA
clone, pRRt592; this probe contained only 39 bp of sequence identified as encoding a putative leader sequence of an extensin precursor polypeptide and hybridised to the same 1.0 kb fragment as was detected by the pRRt566 probe. A 3' flanking sequence prc~e from pRRt566 was prepared by subcloning a Hinc II-EcoRI fragment into pUC 18. This probe contained no coding sequence, which hybridises very strongly due to its G-C rich nucleotide composition. The 3' probe failed to hybridise to lambdaB31 DNA suggesting that thls clone contained the 5' end and coding sequence of an extensin gene, but either lacked the 3' flanking sequence, or was divergent in the 3' flanking region.
When the 1.0 kb fragment of lambdaB31 was labelled and used as a probe on Southern blots of restricted rape genomic DNA, similar results (not shown) to those o~tained when pRRt566 was used as a probe, were obtained. A 1.85 kb Hinc II fragment of genomic DNA which was present at 1 copy per haploid genome, corresponded to the expected Hinc II
fragment predicted from the lambdaB31 restriction map.
Se~uence of extensin aene extA
Approximately 2.7 kb of DNA sequence of the genomic . . .
: ' :
WO9l/l3992 PCT/GB91/00416 2 ~7 ~ 3 2 1 - 12 -clone lambdaB31 was fully determined. The 5.3kb HindIII-AvaI fragment from lambdaB31 was subcloned into pUC18 (Yanisch-Perron et al, Gene 33, 103-119, 1985) to give pRlambdaS4 (Figures 2 and 3) from which the 2.7kb HincII-HincII fragment was sequenced (Figure 2). The sequencing map for this region is shown in Fig. 2, and the complete determined sequence is given in Fig. 1. The sequence contains an open reading frame predicting a polypeptide of 299 residues. The first 23 residues of the sequence encode a leader sequence, when compared with other extensin sequences and as defined by the rules of von Heijne (1985, J. Mol. Biol. 184, 99-105). The remainder of the I coding sequence encodes a highly proline-rich polypeptide of 276 amino acids.
The promoter of the invention is the 5' flanking sequence of the extA gene as shown in Figure 1. This sequence contains a sequence (CTATATAAA) closely homologous to the consensus "TATA" ~ox for plants seventy-four bases 5' to the initiation codon. Apart from this no significant features can be recognised. Comparison of this 5' flanking sequence with that of the carrot extensin gene pDC5Al (Chen and Varner, EMBO J. 4, 2145-2151, 1985) reveals no strongly conserved sequence regions, apart from the "TATA" box.
Expression of extA
To confirm that extA represents an expressed gene, and to determine its transcription start, a series of Sl mapping experiments were carried out. Fragments of extA 5' t~` end-labelled at a Dde I site (base 71) and extending in a 5' direction to the Nsi I site (base -74) or the Dde I site (base -237) were isolated and hybridised to poly(A)+RNA from rape roots. ~fter treatment with Sl nuclease, the protEcted fragments were sized by polyacrylamide gel electrophoresis.
In bo~h cases, protected fragments of 66-75 bases were obtai~ed with the strongest band corresponding to the underlined base in the sequence TAAGAGC_TCAAAC, which was .' ' : .. . .- - . ,, ,. , . . - , :
: ...... . . . . .
. ~ ~ . . , , . . ' ; ' . :
. ' ; ' . . : . ' ' : , . .: .:
W 0 91/13992 PCr/CB91/00416 ,~`' - 13 - 2~7~327 designated base +l (indiated in Figure 1 by T^S). This sequence is in good agreement with the consensus transcription start in plants, -CATC- and is at a congruous distance from the "TATA" box (34 bases). No other protected fragments that were not also present in the controls were observed. A further probe, labelled at the Nde I site at base -86 and extending to the Nde I site at base -453, was prepared and hybridises as above. No protected fragments of this probe were observed, although a small amount of intact probe was present in both the experimental and control hybridisations. These results suggest that the determined transcription start is the only start site in extA, in contrast to the carrot extensin gene where two transcription start points were observed.
To confirm the above conclusions, and to investigate the organ-specificity of expression of extA, fragments of the gene were used as probes on Northern blots of RNA from different rape organs. A probe consisting of the complete coding sequence of the gene, and extending to base -74, was hybridised to RNA from four rape organs: root, green leaf, etiolated leaf and developing seed. This probe hybridised to two mRNA species in root, of approx. 1300 and 1480 bases, and hybridised only very weakly to a mRNA
species in developing seeds, of approx. 1600 bases. This hybridisation pattern is very similar to that given by the cDNA species pRRt556 (and closely homologous species), and rehybridisation of the same blot to the cDNA probe confirmed that the same bands were detected by both probes. If the size of 3' flanking sequence of pRRt566 is added to that of the sequence of extA, the completed gene would be predicted to produce an mRNA species of approx. 1250 bases, assuming a poly(A) tail of 30-bases is added to the cDNA sequence. The observed mRNA species of approx. 1260 bases in rape roots can ~herefore be suggested to be the product of extA. A
very low level of hybridisation of the extA probe to a large mRNA species (approx. 4.6 kb) pres~nt in root was also ' . ` ' . ... . , , , .. . . , : ..
,. . : -:
~ 3~ - 14 -observed.
EXAMPLE 2: Expression of the extA_in_Transgenic Tobacco The original rape extA gene as isolated from the lambdaB31 clone lacked a 3' terminator region due to the cloning strategy used (Figure 4). Accordingly, a 260bp nopaline synthase (nos) BamHI-EcoRI fragment which contains an efficient plant terminator sequence was excised from the clone pNOP-NEO and ligated into BamHI-EcoRI cut pUC18 and cloned in E. coli DH5h. pNOP-NEO is a clone containing -the NOS promoter linked to the Neomycin Phosphotransferase (NPT) gene which encodes kanamycin resistance, linked to the NOS terminator as published by Bevan, Nucleic Acids Research 2, 8711-8721 (1984).
The extA gene, excised from pRlambdaS4 on a 4.75kb HindIII-SalI fragment, was then ligated into the NOS
terminator pUC18 clone, also restricted with HindIII-SalI, and cloned in E. coli DH5~. The final extA - NOS terminator construct is shown in Figure 5. The whole extA - NOS
terminator construct was then excised on an intact 5.01kb HindIII-EcoRI fragment and ligated into the binary vector pBIN19 (Bevan, 1984) restricted with HindIII-EcoRI, and cloned into E. coli MC1022. The final hybrid gene construct designated pBINl9:extA is shown in Figure 6 and contains additionally the endogenous kanamycin resistance gene (NPT) located between the T-DNA borders.
, This construct termed pBINl9:extA was triparentally t ~ mated into A. tumefaciens LBA4404 and used to transform leaf discs of Nicotiana tabacum (SRl). Prior to tobacco being ' used as a test transgenic system, Southern blotting experiments were performed on tobacco DNA to show that , hybridisation of extensin coding region to tobacco DNA did ; not occur. Even at low stringency no hybridisation of the extensin coding region to tobacco DNA could be seen. In detail:
~, ,-, ~
:- :: : . . . . . .
. .. .. . . . . .. . .
. ... . - , .. ,, . . , : , :
~: : . , . .. , . : . . . .
WO9l/l~992 PCT/GB91/00416 2~7~327 Bacterial strains and coniuqations The vector plasmid pBIN19 in Escherichia collstrain MC1022 (Bevan, Nucl. Acids Res. 12, 8711-~721, 1984), the mobilising E. coli strain HB101/pRK2013 (Ditta et ai, PNAS USA 77, 7347-7351, 1980) and the host Aarobacterium tumefaciens strain LBA4404/pAL4404 (Hoekema et al, Nature 303, 179-180, 1983) were used. For bacterial conjugation antibiotics were used at the following concentrations:
kanamycin acid sulphate, 50~g.ml 1 (kan); rifampicin, lOO~g.ml 1 (rif~; streptomycin sulphate, 500 ~g.ml 1 (strep). The recombinant vector BINl9:ext A was mobilized in a triparental mating by mixing 200~1 each of overnight cultures of E. coli MC1022/BIN19 (kanR, strepS, rifS), E.
coli HB101/pRK2013 (kanR, strepS, rifS) and A. tumefaciens LBA4404 (kanS, strepR, rifR), and incubating at 27C on a L3 plate without antibiotic selection for 15h. The cell mixture was then diluted with 10 mM MgS04; plated out on minimal medium containing kanamycin and incubated at 27C
.or 4 days. The A. tumefaciens LBA4404 colonies were checked for the correct antibiotics resistance markers (kanR, strepR, rifR), and further analysed by colony hybridisation and Southern analysis to confirm that the nPt and ext A genes were present in an intact, unrearranged form in the BINl9:ext A plasmid.
~ .
Tobacco transformation and reqeneration Agrobacterium tumefaciens LBA4404/pBINl9:ext A was cultured in LB medium containing 20~g.ml 1 kanamycin at 27C, the bacteria were pelleted, washed three times in 2 m~
MgS04, and resuspended in MS salts (Flow Labs., Rickmansworth, Herts., UK), lOmg.ml 1 sucrose (pH 5.8) at a density of approx 109 cells.ml 1.
Expanded leaves from well-watered N. tabacum (SRl) plants were surface-sterilized with 70~ (v/v) ethanol (30 s) followed by 5% (w/v) Ca(OCl)2 (15 min). After washing in sterile water, each leaf was cut into squares (approx. 8 x ., :
:, .
.. . . . . . . . .
.:
.. . .
, ,. . .: .- . . . : ..
.-.,. : . , :
.: . . ~ . ,:
WO91/13~92 PCT/GB9t/004t6 m~2) avoiding major veins and then placed in the bacterial suspension, which was intermittently agitated to wet the cut leaf-edges. After 10-15 min. incubation (22-25C) the leaf pleces were placed (adaxial surface upwards on agar plates of shoot-induction medium, comprising MS salts (including vitamins), 10 mg.ml 1 sucrose, 2 ~g.ml 1 N~
furfurylaminopurine (kinetin), 0.2 ~g/ml 1 1-naphthylacetic acid (pH 5.8) and 8 mg.ml 1 bacto-agar, and cultured at 25C, 18-h photoperiod (120~mol.m 2.s 1 PAR). After 2 days the leaf pieces were transferred to liquid shoot-ir,duction medium containing 1 mg.ml 1 carbenicillin (disodium salt) and gently agitated (60 rpm shaker) overnight. The leaf pieces were surface-dried on sterile absorbant paper and placed on agar plates of shoot-induction medium containing 500 ~g.ml 1 carbenicillin, 200 ~g.ml 1 kanamycin (acid sulphate) and cultured under the conditions described above.
Shootlets which developed from the cut edges of the leaf explants (four to six weeks from inoculation) were excised and transferred to agar plates of half-strength MS
salts, 5 mg.ml 1 sucrose, 250 ~g.ml 1 carbenicillin, 200 ~g.ml 1 kanamycin (pH 5.8). The shootlets which continued to expand were transferred to 60-ml sterile vessels (Sterilin, Feltham, Middlesex, UK) containing root-induction medium comprising half-strength MS salts, lOO~g.ml 1 carbenicillin, lOO~g.ml 1 kanamycin and 8 mg.ml 1 agar.
Shootlets which developed roots were transferred to 250-ml sterile glass jars containing half-strength MS salts, 50 ~g.ml 1 carbenicillin and 8 mg.ml 1 agar. When the plantlets had developed an extensive root system, they were removed from culture and potted in 1:1 Levington compost:perlite (Silvaperl Products, Harrogate, UK), and grown in a controlled environment with daily watering.
Tissues from the transgenic plants were harvested into liquid air for extraction of DNA, for genomic analysis to assess the integrity of the transferred gene, and RNA, for analyses of extensin gene expression. The potted plants ' WO91/13992 PCT/Gn91/004~6 ?`~ " 2 ~ 7 8 3 2 7 flowered after about five weeks, and following self-pollination, the seeds from each plant were collected at dehiscence.
Extraction of DNA and Southern Analvsis The DNA from N. tabacum leaves was extracted and purified. The DNA probes for hybridization were 32P-labelled to high specific activities (>8 x 1011 Bq.~g 1) using random priming according to Feinberg and Vogelstein (Anal. Biochem. 132, 6-13, 1983). Standard techniques were used for Southern transfer and hybridization and high stringency (30 mM NaCl, 3 mM Na3 citrate, 65C, 60 min) was employed in the final post-hybridization wash. Filters were autoradiograhed for 72 h at 80C using flashed X-ray film (Fujimex, Swindon, UK) and intensifying screens (Du Pont, Stevenage, UK).
Extraction of RNA and Northern AnalYsis Total RNAs from tissues of the transgenic N.
tabacum plants were isolated by the procedure of Logemann et al. (Anal. Biochell. 163, 16-20, 1987). To estimate the size of RNAs specifically hybridizing to the rape extensin probe, 10~g of each sample RNA was glyoxalated, run on agarose -- gels, and transferred to nitrocellulose. Northern blots were washed to high stringency (15 mM NaCl, 1.5 mM Na3 ` citrate, 0.1~ sodium dodecyl sulphate (SDS), 25 min, 50C), and the filters autoradiographed for 2 weeks as described above.
Fifteen transgenic tobacco plants were regenerated i and grown from the initial transformation experiment.
Samples of leaf and root were collected for analyses by Southern and Northern blotting. The majority of the transgenic plants regenerated contained intact, unrearranged copies of the introduced hybrid extensin gene. Estimates of the copy number of the introduced gene in the various independent transformants varied from one copy to five - copies. Only trans~enic tobacco plants containing intact, unrearranged copies of the introduced gene were used for , .,:
,, .
- , , - ., , : ~ , .
-.
- : : , , ,: ~ . :
~ , . , ~-, ' .: . . . . .. .
.
WO91/1399~ PCT/GB9l/00416 ~7832~ ~
further analysis of extensin expression.
Because of the lack of availability of specific rape extensin antibodies, Northern hybridisations were performed on total RNA extracted from tobacco leaf and root tissues, using the extensin l.0 kb coding sequence from the genomic clone lambdaB31 as a probe. No hybridisation to leaf RNA from either control or transformed tobacco plants was seen. Hybridisation of the extensin probe to transgenic root RNA was seen in all the transformants tested, although the level of hybridisation between individual transformants varied (position effect).
Seeds were collected from the initial batch of transformed tobacco, and were sown in compost. Plants were grown from this seed.
EXAMPLE 3: Expression of Glucuronidase Enzyme under Control of the Rape Promoter In order to see the expression of the rape gene extA in rape, the rape promoter from lambdaB31 was fused in a translational fusion to the coding sequence of the glucuronidase (GUS) gene in a binary vector variant of 8IN19. The clone containing the construct was mated with an Aarobacterium strain (LBA 9402) containing an oncogenic Ri plasmid, pRi 1885 (Constantino et al, Plasmid 5, 170-182, 1981). Inoculation of this strain into rape seedlings produces transgenic hairy roots, which are then easily assayable for GUS activity. Whole plants can be regenerated from excised transgenic hairy roots.
In detail, the rape extensin promoter was excised from pRlambdaS4 as a l.Okb HaeIII-HaeIII fragment. This fragment was blunt-end ligated into a modified pBINl9 binary vector, pBIlOl containing a promoterless glucuronidase (GUS) gene, restricted with SmaI at the start of the GUS coding sequence (see Jefferson, Plant Molecular Biology Reporter 5, 387-40S, 1987) (Figure 8). The rape promoter expression .~ from this translational fusion will give a glucuronidase : ` ~
., ~ .
'I
, - , : ~ , . .. ~ .
. ~ . , . . . :
, . . .
- . . ,.; ; , . : .: , -., ~ , ~ . , . :
WO91/13992 PCT/GBgl/00416 2~7~327 enzyme with either 7 or 11 extra amino acids at the N-terminus, depending on which rape ATG is used as the translation initiation codon.
The extA-GUS hybrid gene in pBI101 (pBIlOl:extA-GUS) was cloned in E. coli MC1022 and then transferred into Aarobacterium tumefaciens or Aqrobacterium rhizogenes by tri-parental matings with the appropriate Agrobacterium strains. Preliminary results to test for expression from this construct, using the X-Gluc (5-bromo~4-chloro-3-indolyl-~-D-glucuronide) histochemical assay of Jefferson (Plant Molecular Biology Reporter 5, 387-405, 1987) in rape 'hairy roots' transformed with Aarobacterium rhizoqenes containing pBIlOl:extA-GUS, have clearly shown that the promoter is active in rape root tissue.
Ra~e Tissue culture and transformation ~rotocols:
Transformation experiments usina A. rhizoqenes Axenically growing seedlings of B. na~us cv.
Bienvenue (winter rape), Brutor and Rapid Cycling were inoculated at their cotyledonary nodes with an A. rhizoqenes LBA9402 strain carrying both the Ri plasmid pRi 1855 (Constantino et al, 1981) and the kanamycin resistance fusion construct of Figure 8 (pBIlOl:extA-GUS) as separate independent replicons. Hairy roots arising from the site of inoculation can be excised and grown in a culture medium (1 x MS salts and vitamins, 4% sucrose, 2 g/l CaC12.H20, 0.1 mg/1 NAA, 2.5 mg/l BAP) 0.1 mg/l thiamine, 200 mg/l cephotaxime, 50-mg/1 kanamycin, 8 g/l Bacto Difco agar, pH
5.8, to proliferate the hairy roots.
Regeneration can be achieved as follows: 0.5 cm sections of the terminal 2 - 3 cm of hairy roots are excised, treated with 2,4 - D at a concentration of 3 mg/l, and plated on shooting medium containing kanamycin at 50 mg/l to select for tissues which contained the T-DNA
kanamycin gene of the fusion construct of Figure 8. Shoots arising from these hairy roots are excised and grown on medium F of Pelletier et al (Mol. Gen. Genet. 191, 244-250 ~. ' ~ ' .
~,~., ' .
.`
~ ' , ' ' ' ' ' ~ ~', . . .
WO91/1399' PCr/GB91/00416 ~, ,-%~32~ - 20 -(1983)) for 2-3 weeks. They are then transferred to rooting medium G, and when a sufficient root system has developed they are transferred to soil and grown to maturity in a containment growth room.
Transgenic winter rape plants are vernalised to induce flowering by growing them at 4C with a 8h daylight period. Flowers are emasculated before anthesis and outcrossed with wild type rape pollen. Seeds obtained after pod set are collected, sown in soil and the progeny plants grown to maturity. The progeny plants are initially scored visually with regard to the degree of the hairy root syndrome being exhibited. Kanamycin resistance in the leaves of the progeny is assayed by transferrlng leaf discs to callus inducing media (see below) containing kanamycin at ; either 50 or 150 mg/l. Both the Ri and the kanamycin resistance traits can be further confirmed by Southern -~ hybridisation analysis.
The media used in the Examples are:
Media 1. For seedlina arowth MS salts 2.355 g/l Sucrose 20 g/l Difco Bacto agar 15 g/l pH
5.8 2. For Aarobacterium rhizoaenes liauld culture - YMB
~ Mannitol 10 g/l ,; Yeast extract 0.4 g/l KH2P04 0.5 g/l MgS4 2H2 0.2 g/l NaCl 0.1 g/l Kanamycin 50 mg/lpH 7.0 , 3. For hairv root culture (Ooms' medium: Ooms et al (1985) Theor. Appl. Genet. 71, 325-329) '.
, , . -- .
,: .
.~.
.. , , ~. .
:, -. ,; , ::, . . :: . . . : ., PCr/~B91/00416 2~178327 MS salts 4.71 g/l CaC12.2H20 2 g/l Sucrose 40 g/l NAA 0.18 mg/l BAP 2.5 mg/l Thiamine HCl 0.1 mg/l Difco Bacto agar 8 g/l Xanamycin 25 or 50 mg/l Cephotaxime 200 mg/l pH 5.8 4. For shoot induction, multi~lication and rootina D solution, RCC medium, F and G media are as described by Pelletier et al. (1983) and Guerche et al.
(Mol. Gen. Genet. 206, 382-386, 1987). In addition, a level of Cephotaxime of 200 mg/l is maintained in all these media at all times. ~
5. Callusinq medium for transformed N. tabacum and rape -leaf discs MS3SC 100 kan.
- MS salts 4.7 g/l ~, Sucrose 30 g/l - NAA 2 mg/l Kinetin 0.2 mg/l Kanamycin 100 mg/l Agar 8 g/l .
. "~
. ., ..
. 1 ' ~ .
, .
~,, . ~ "
- ~
, , .-. ., .. , ... .. ; .
- MS salts 4.7 g/l ~, Sucrose 30 g/l - NAA 2 mg/l Kinetin 0.2 mg/l Kanamycin 100 mg/l Agar 8 g/l .
. "~
. ., ..
. 1 ' ~ .
, .
~,, . ~ "
- ~
, , .-. ., .. , ... .. ; .
Claims (13)
1. A promoter which is capable of directing protein expression in roots in plants and which has:
(a) the sequence from nucleotide -1616 to nucleotide -1 shown in Figure 1 or a part of the said sequence or (b) a said sequence (a) modified by one or more nucleotide substitutions, insertions and/or deletions and/or by an extension at either or each end.
(a) the sequence from nucleotide -1616 to nucleotide -1 shown in Figure 1 or a part of the said sequence or (b) a said sequence (a) modified by one or more nucleotide substitutions, insertions and/or deletions and/or by an extension at either or each end.
2. A DNA fragment comprising a promoter as claimed in claim 1 operably linked to a gene encoding a protein.
3. A vector which comprises a gene, encoding a protein, under the control of a promoter as claimed in claim 1, such that the gene is capable of being expressed in a plant cell transformed with the vector.
4. A vector according to claim 3, wherein the promoter is fused directly to the 5'-end of the said gene.
5. A vector according to claim 3 or 4, which further contains a region which enables the gene and the promoter to be transferred to and stably integrated in a plant cell genome.
6. A vector according to any one of claims 3 to 5, which is a plasmid.
7. A plant cell which has been transformed with a vector as claimed in any one of claims 3 to 6.
8. A plant cell which harbours a promoter as claimed in claim 1 operably linked to a gene encoding a protein.
9. A transgenic plant which has been regenerated from plant cells as claimed in claim 7 or 8.
10. A transgenic plant which harbours in its cells a promoter as claimed in claim 1 operably linked to a gene encoding a protein.
11. Seed obtained from a transgenic plant as claimed in claim 9 or 10.
12. Plants grown from seed as claimed in claim 11.
13. A method of producing a transgenic plant capable of producing a desired protein in the roots of the plant, which method comprises:
(i) transforming a plant cell with a vector as claimed in any one of claims 3 to 6, the protein encoded by the gene under the control of the said promoter being the desired protein; and (ii) regenerating plants from the transformed cells.
(i) transforming a plant cell with a vector as claimed in any one of claims 3 to 6, the protein encoded by the gene under the control of the said promoter being the desired protein; and (ii) regenerating plants from the transformed cells.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB909005945A GB9005945D0 (en) | 1990-03-16 | 1990-03-16 | Plant promoter |
GB9005945.2 | 1990-03-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2078327A1 true CA2078327A1 (en) | 1991-09-17 |
Family
ID=10672722
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002078327A Abandoned CA2078327A1 (en) | 1990-03-16 | 1991-03-18 | Plant promoter |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0521910A1 (en) |
JP (1) | JPH07501683A (en) |
CA (1) | CA2078327A1 (en) |
GB (1) | GB9005945D0 (en) |
WO (1) | WO1991013992A1 (en) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5618988A (en) * | 1990-03-02 | 1997-04-08 | Amoco Corporation | Enhanced carotenoid accumulation in storage organs of genetically engineered plants |
EP0452269B1 (en) * | 1990-04-12 | 2002-10-09 | Syngenta Participations AG | Tissue-preferential promoters |
US5459252A (en) * | 1991-01-31 | 1995-10-17 | North Carolina State University | Root specific gene promoter |
ZA927576B (en) * | 1991-10-04 | 1993-04-16 | Univ North Carolina State | Pathogen-resistant transgenic plants. |
US5401836A (en) * | 1992-07-16 | 1995-03-28 | Pioneer Hi-Bre International, Inc. | Brassica regulatory sequence for root-specific or root-abundant gene expression |
US5744693A (en) * | 1992-10-02 | 1998-04-28 | California Institute Of Technology | Plants having altered floral development |
US6008436A (en) * | 1993-01-21 | 1999-12-28 | North Carolina State University | Nematode-resistant transgenic plants |
US5837876A (en) * | 1995-07-28 | 1998-11-17 | North Carolina State University | Root cortex specific gene promoter |
JP3791059B2 (en) * | 1996-08-12 | 2006-06-28 | 住友化学株式会社 | Plant promoters and their use |
US6586661B1 (en) | 1997-06-12 | 2003-07-01 | North Carolina State University | Regulation of quinolate phosphoribosyl transferase expression by transformation with a tobacco quinolate phosphoribosyl transferase nucleic acid |
EP1131450B1 (en) | 1998-11-12 | 2012-01-25 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Chimeric promoters capable of mediating gene expression in plants upon pathogen infection and uses thereof |
DE19852757A1 (en) * | 1998-11-16 | 2000-05-18 | Eth Zuerich Zuerich | Promoters for gene expression in the roots of plants |
FR2795424B1 (en) * | 1999-06-25 | 2003-12-05 | Agronomique Inst Nat Rech | PROMOTER EXPRESSED SPECIFICALLY IN THE ROOT CELLS OF RECOMBINANT PLANTS, VECTORS AND HOST CELLS INCLUDING SUCH A PROMOTER AND TRANSGENIC PLANTS OBTAINED |
KR20030029885A (en) | 2000-08-30 | 2003-04-16 | 노쓰 캐롤라이나 스테이트 유니버시티 | Transgenic plants containing molecular decoys that alter protein content therein |
CA2427825A1 (en) | 2000-11-07 | 2002-05-16 | North Carolina State University | Putrescine-n-methyltransferase promoter |
CN101029308B (en) | 2001-02-08 | 2012-07-25 | 赫希玛有限公司 | Plant derived molecule, genetic coding sequence and its uses |
AU2003902253A0 (en) | 2003-05-12 | 2003-05-29 | The University Of Queensland | Method for increasing product yield |
EP1555321A1 (en) | 2004-01-15 | 2005-07-20 | Institut National De La Recherche Agronomique | CCaMK involved in nodulation and endomycorrhization |
MX2010005937A (en) | 2007-11-27 | 2010-06-15 | Commw Scient Ind Res Org | Plants with modified starch metabolism. |
EP2315519B1 (en) | 2008-07-21 | 2016-08-17 | Commonwealth Scientific and Industrial Research Organisation | Improved cottonseed oil and uses |
EP2328404B1 (en) | 2008-08-25 | 2014-04-30 | Commonwealth Scientific and Industrial Research Organisation | Resistance genes |
CA2921784C (en) | 2013-08-21 | 2023-03-07 | Commonwealth Scientific And Industrial Research Organisation | Lr67 rust resistance gene which confers plant resistance to a biotrophic fungal pathogen |
WO2016110411A1 (en) * | 2015-01-08 | 2016-07-14 | Bayer Cropscience Nv | Root-preferential promoters and uses thereof |
SG11201804169QA (en) | 2015-11-18 | 2018-06-28 | Commw Scient Ind Res Org | Rice grain with thickened aleurone |
-
1990
- 1990-03-16 GB GB909005945A patent/GB9005945D0/en active Pending
-
1991
- 1991-03-18 EP EP19910906083 patent/EP0521910A1/en not_active Withdrawn
- 1991-03-18 CA CA002078327A patent/CA2078327A1/en not_active Abandoned
- 1991-03-18 JP JP3505831A patent/JPH07501683A/en active Pending
- 1991-03-18 WO PCT/GB1991/000416 patent/WO1991013992A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO1991013992A1 (en) | 1991-09-19 |
GB9005945D0 (en) | 1990-05-09 |
EP0521910A1 (en) | 1993-01-13 |
JPH07501683A (en) | 1995-02-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2078327A1 (en) | Plant promoter | |
US5750871A (en) | Transformation and foreign gene expression in Brassica species | |
US5188958A (en) | Transformation and foreign gene expression in brassica species | |
AU645990B2 (en) | Regulatory DNA sequence | |
US8338662B2 (en) | Viral promoter, truncations thereof, and methods of use | |
US5612472A (en) | Plant promoter | |
US8395022B2 (en) | Viral promoter, truncations thereof, and methods of use | |
US8350121B2 (en) | Viral promoter, truncations thereof, and methods of use | |
US20120167249A1 (en) | Viral promoter, truncations thereof, and methods of use | |
US5723757A (en) | Plant promoters specific for sink organ expression of genes | |
US6281410B1 (en) | Methods and compositions for regulated transcription and expression of heterologous genes | |
US7557264B2 (en) | Gossypium hirsutum tissue-specific promoters and their use | |
KR20000015750A (en) | Method for reducing interval of inflorescence section according to the introduction of transcription factor, petspl2 obtained from petunia | |
US20040191912A1 (en) | New constitutive plant promoter | |
US8344206B2 (en) | Viral promoter, truncations thereof, and methods of use | |
US7199235B2 (en) | Plant promoters | |
EP1172441A1 (en) | A promoter derived from phytosulfokine precursor gene | |
KR100432534B1 (en) | Asexually producible plant for shortening internode of inflorescence by introducing gene for petunia transcription factor PetSPL2 | |
AU2002314611A1 (en) | Callus specific plant promoters | |
AU2002314612A1 (en) | Constitutive plant promotor | |
JP2004049143A (en) | Infection-inducing pr4 gene promoter | |
WO2015038622A1 (en) | Plant regulatory elements and methods of use thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Discontinued | ||
FZDE | Discontinued |
Effective date: 19950918 |